Under standard assay conditions, with 1-chloro-2,4-dinitrobenzene (CDNB) as electrophilic substrate, rat glutathione transferase 4-4 is strongly inhibited (I50 = 1 PM) by indomethacin. No other glutathione transferase investigated is significantly inhibited by micromolar concentrations of indomethacin. Paradoxically, the strong inhibition of glutathione transferase 44 was dependent on high (millimolar) concentrations of CDNB; at low concentrations of this substrate or with other substrates the effect of indomethacin on the enzyme was similar to the moderate inhibition noted for other glutathione transferases. In general, the inhibition of glutathione transferases can be explained by a random-order sequential mechanism, in which indomethacin acts as a competitive inhibitor with respect to the electrophilic substrate. In the specific case of glutathione transferase 4-4 with CDNB as substrate, indomethacin binds to enzyme-CDNB and enzyme-CDNB-GSH complexes with an even greater affinity than to the corresponding complexes lacking CDNB. Under presumed physiological conditions with low concentrations of electrophilic substrates, indomethacin is not specific for glutathione transferase 4-4 and may inhibit all forms of glutathione transferase.
INTRODUCTION
Indomethacin is an anti-inflammatory drug that inhibits the cyclo-oxygenase (Vane, 1971 ) and lipoxygenase (Siegel et al., 1979; Wu & Mathews, 1983) pathways of arachidonate metabolism. It thereby prevents the production of leukotrienes and related compounds directly responsible for inflammatory effects. Clinical treatment with indomethacin is known to give rise to certain side effects that indicate that the action of the drug is not limited to anti-inflammatory action. Indomethacin has also been shown to inhibit 02 uptake by gastric mucosal mitochondria (Priess & Sewing, 1985) and to have antitumoral activity (Rubio, 1984) .
Glutathione transferase is among the enzymes that have been found to be inhibited by indomethacin (Wu & Mathews, 1983) . Cytosolic glutathione transferases are dimeric proteins consisting of identical or non-identical subunits. Multiple forms of glutathione transferase have been isolated, characterized and grouped into one of three classes . Within the same class the subunits are highly homologous and can hybridize with each other, even though there may be large differences in their substrate and inhibitor specificities. For example, 0rat subunits 3 and 4 display 77 % sequence identity (Alin et al., 1986; Ding et al., 1986; Lai et al., 1986) and form a hybrid (transferase 3-4), but have distinct catalytic properties (Alin et al., 1985b) . The functional properties of different forms of glutathione transferase appear to reflect the structure of their respective active-site regions (Danielson et al., 1987) . A variety of substrates and inhibitors may be used in the identification of different enzyme forms . The inhibition by indomethacin has been especially useful for identification of rat glutathione transferase 4-4, which is the only form strongly inhibited by this compound in the standard assay system (Nicholls & Ahokas, 1984; Alin et al., 1985b; Tahir et al., 1985; Warholm et al., 1986) . The comparatively weaker inhibition by indomethacin of, for example, the homologous form transferase 3-3 may be due to a different overall reaction mechanism, a different mode of inhibition or a combination of these factors. The kinetics of rat transferases 3-3 (Jakobson et al., 1977) and 1-1 (Schramm et al., 1984) previously studied are consistent with a sequential mechanism with random-order addition of GSH and the electrophilic substrate. Neither the reaction mechanism of transferase 4-4 nor the mode of inhibition by indomethacin, with any enzyme form, has been reported previously.
Glutathione transferase is known as an important detoxication enzyme acting on endogenous and exogenous compounds (for a review see Mannervik, 1985) . The physiological effect of indomethacin inhibition of glutathione transferase may involve impaired detoxication. Another potential effect may be inhibition of the biosynthesis of leukotriene C4, since it is also recognized as an enzyme capable of catalysing the conversion of leukotriene A4 into the GSH conjugate leukotriene C4 (Mannervik et al., 1984) . Glutathione transferase 4-4 is the form most sensitive to indomethacin inhibition and also the cytosolic transferase most active with leukotriene A4 as substrate (Mannervik et al., 1984) .
The present investigation was undertaken in order to determine the reaction mechanism of rat glutathione transferase 4-4 and the mode of action of indomethacin in vitro, as well as to find out if, under physiological conditions, this enzyme form has a unique sensitivity to indomethacin as compared with other glutathione transferases.
MATERIALS AND METHODS
Glutathione transferases were isolated from rat liver by the procedure described by Alin et al. (1985b) . The chemicals used were standard commercial compounds of highest purity.
The inhibition of glutathione transferase activity was determined at several different concentrations of substrate. The concentration of inhibitor giving 500 inhibition (I50) was used as a measure of the inhibitory effect at a given substrate concentration. The 150 value for the classical linear inhibition patterns of the Michaelis-Menten equation (Cleland, 1963) ; in the present investigation it was found to be a valuable complement to conventional kinetic analysis, especially for defining the inhibition type.
A range of 0-100 ,#M-indomethacin was sufficient to determine the I50 value for transferase 4-4 at substrate concentrations of 3 #M-, 10 /M-, 30 /tM-, 100 LM-, 300 gMand 1000 1tM-1-chloro-2,4-dinitrobenzene (CDNB) and of4 JtM-, 10/M-, 40 /LM-and 100 /tM-trans-4-phenylbut-3-en-2-one (tPBO). The concentrations cover the maximal ranges possible for accurate measurements with these substrates. The enzyme concentration was 4-40 nm. A standard assay system containing 0.2 M-sodium phosphate buffer, pH 6.5, 5 % (v/v) ethanol and 1 mm-GSH (for CDNB) or 0.25 mM-GSH (for tPBO) was used at 30 'C. The initial velocity was determined in each point as the average of at least five replicates, and the standard deviation was used as a measure of the experimental error. The 15 value was also determined with 4-hydroxyalk-2-enals as0 substrate; the activity was measured as described by Alin et al. (1985a) , except that 2.5 mM-GSH and different concentrations of 4-hydroxyalkenal were used.
Non-linear-regression analysis was performed essentially as described previously (Mannervik, 1982; Mannervik et al., 1986) . The experimental error in the kinetic data was not constant, as judged from the replicate measurements. Consequently, empirical error functions were determined by fitting the estimated standard deviations (S.D.) to alternative models by the procedures previously described . The best error models were based on substrate and inhibitor concentrations and were subsequently used to define weighting factors in the regression analysis of the kinetic data sets. For data (31 experimental points with at least five replicates) in which tPBO served as substrate the best error function was: 
RESULTS
In order to characterize the effect of indomethacin on glutathione transferases, the inhibition was studied under different conditions. The inhibition of transferases 4-4 and 3-3 was initially measured at high and at low concentrations of the substrates CDNB, tPBO, 4-hydroxdec-2-enal and 4-hydroxyhex-2-ena,l. These 4-hydroxyalkenals are homologous substrates giving high and low activity respectively with the transferases studied. All Danielson & Mannervik, 1985) , are also given.
The data show that indomethacin is a particularly 
Inhibition of transferase 4-4
The unique effect of indomethacin on transferase 4-4 was further investigated by studies of the inhibition at different concentrations of tPBO and CDNB. Fig. 1 shows the activity as a function of the indomethacin concentration at different concentrations of CDNB (Fig.  la) and tPBO (Fig. lb) . The shape of the curves and the effect of substrate concentration are clearly different in the two cases. Determination of rate equation and reaction mechanism Initial-velocity data from the inhibition studies involving transferase 4-4 and indomethacin were analysed in order to determine a rate equation for each of the two substrates CDNB and tPBO (Fig. 1) (Mannervik, 1978) with tPBO and non-competitive with CDNB, in agreement with principles described in the Materials and methods section.
The by using the parameter values obtained by regression analysis kcat/Km was calculated to be 0.084#UM-1 s-1, which is slightly higher than, but not significantly different from, the published value of 0.065/tM-l S-s (Danielson & Mannervik, 1985) . The predicted value represents the maximal rate of the reaction under firstorder conditions with respect to tPBO concentration.
The 50 value can be expressed as a function of tPBO concentration [S] and parameters of the underlying rate equation (cf. that was adequate for the data obtained with tPBO as substrate ( Table 2) .
The simplest mechanism accurately describing the inhibition when CDNB was used as substrate is presented in Scheme 2. The essential features are the same as for the tPBO reaction (Scheme 1), with the addition of ECI and EGCI complexes. (Mannervik, 1982) . Additional pathways in the reaction scheme, e.g. El = ECI and EGI = EGCI, are also possible, but the data analysis did not call for corresponding third-or fourth-degree terms in the rate equation. On the other hand, under the experimental conditions (i.e. high CDNB concentration) that favour the reaction loop involving ECI and EGCI, the concentrations of E and EG are low, disfavouring pathways including these enzyme forms. Consequently, the simplest scheme involving the essential features of the kinetics has been adopted.
The value for kCat 1Km predicted by this mechanism is Pl/P5 = 0.16 #m-uW s-, which is close to the published value of 0.19im-1 -s-1 (Alin et al., 1985b) .
The rate equation and parameters presented in Table  4 were used to calculate the inhibitor concentration giving 50 % of the uninhibited reaction rate. These 150 values, predicted by the model, are presented with the experimental values in Table 5 .
The model presented in Scheme 2 explains the noncompetitive behaviour versus CDNB as well as GSH. Alternative models considered, but rejected, involved the production of enzyme-product-inhibitor complexes, and consequently predicted increased inhibition by addition of the products Cl-and S-(2,4-dinitrophenyl)- glutathione. However, these products even at high concentration were not found to affect the strength of the inhibition (results not shown).
DISCUSSION
The kinetic reaction mechanism proposed for glutathione transferase 4-4 was found to be consistent with a steady-state random-order mechanism for both CDNB and tPBO as second substrate (Schemes 1 and 2) . GSH was present at near saturating concentrations in the experiments and was not explicitly accounted for in the rate equation. However, the data require a model including two forms of substrate-free (E and EG) and two forms of substrate-containing (ES and EGS) enzyme, representing the species with and without bound GSH.
The inhibition mechanism involves the binding of inhibitor to more than one enzyme form. In the experiments with tPBO as substrate, the inhibition was competitive versus tPBO, since indomethacin binds only to forms not including tPBO or product.
The tPBO activity of transferase 4-4 appears to be well characterized by the model, as judged by close agreement of experimental data for kcat /Km and 150 values with those predicted by the model. Alternative rate equations did not represent the data with similar accuracy.
The model presented in Scheme 1 describes the binding of indomethacin to the enzyme forms lacking the second substrate, resulting in EI and EGI complexes. This reaction scheme appears to apply generally for the action of indomethacin on transferase 4-4 as well as the other transferases tested. The exception, however, is transferase 4-4 with CDNB as second substrate, which in addition to the general inhibition pattern also exhibits a kinetically most significant binding of indomethacin to the enzymesubstrate complexes, forming ECI and EGCI. In this case the inhibition increases with the substrate concentration and results in a stronger inhibition than in the simpler case. Maximal inhibition is reached at infinitely high substrate concentrations. This paradoxical inhibition has so far not been observed with any other substrate nor with any other transferase.
In the search for an explanation of the paradoxical inhibition pattern of indomethacin observed when CDNB served as a substrate for glutathione transferase 4-4, several alternatives were excluded. CDNB is a particularly good substrate in comparison with most of the conventional substrates for the glutathione transferases (Alin et al., 1985b) . However, comparison with results obtained with the even better substrate 4-hydroxydec-2-enal shows that the unusual inhibition is not dependent on the rate of the catalytic step, as measured by values of kcat /Km (Table 1) . Further, the differences in the chemical reaction type were not found to be of significance for the inhibition. In the tPBO reaction GSH conjugation takes place by an addition reaction, whereas in the CDNB reaction the conjugate is formed via a substitution reaction, yielding C1-as a second product. However, addition of the products of the CDNB reaction did not enhance the inhibition with indomethacin. Further, the effect of indomethacin on transferase 3-3 is essentially the same with CDNB as with 4-hydroalkenals (cf. Table 1), which argues against mechanism type as a determinant for the strength of inhibition. Other models considered included mnemonical mechanisms (Ricard et al., 1974) , but these were not found to be superior to the model proposed here and depended on assumptions about kinetically distinct conformational states of the enzyme. No experimental support exists for kinetically significant conformational changes under steady-state conditions. Among the rat (Alin et al., 1985b) , mouse and human transferases investigated, none but rat glutathione transferase 4-4 is strongly inhibited by indomethacin. It is particularly remarkable that rat glutathione transferase 3-3, which is structurally most closely related to transferase 4-4, does not show the inhibition properties of the latter isoenzyme. The inhibition of transferase 3-3 with CDNB as substrate is consistent with the general action of indomethacin, as described for the tPBO mechanism for transferase 4-4 (Scheme 1). This is also the behaviour of transferase 3-3 observed with other substrates.
Substrate specificity data suggest that the active site of transferase 4-4 permits the binding of bulky molecules (Danielson et al., 1987) . The binding of indomethacin might therefore be bound in the active-site cavity simultaneously with CDNB. The kinetic data (Table 1 and Fig. la) show that CDNB actually promotes the binding of indomethacin. In contrast, tPBO appears to restrict the binding of indomethacin, as judged by the kinetic data obtained with this substrate.
In contrast with earlier results, based on measurements with high CDNB concentrations, the present investigation demonstrates that the inhibition of glutathione transferases by indomethacin is not limited to transferase 4-4 under physiological conditions, where the electrophilic substrates are assumed to be present in low concentrations. The natural substrates are sought among products of oxidative metabolism such as epoxides, organic hydroperoxides and actived alkenes (Mannervik, 1986) . The maximal inhibition is dependent on the degree of enzyme saturation with a particular substrate. Indomethacin can bind to the free enzyme, and for all substrates studied, except CDNB, a low substrate concentration will give the strongest inhibition. The intracellular concentrations of indomethacin resulting from clinical treatment may inhibit the activity of the enzyme significantly.
The previous findings that rat glutathione transferase 4-4 was both the most active cytosolic enzyme in the formation of leukotriene C4 (Mannervik et al., 1984) and the form most sensitive to indomethacin inhibition (Nicholls & Ahokas, 1984; Alin et al., 1985b) appears to be of less importance for the synthesis of leukotriene C4 in vivo than was initially supposed. Firstly, it has been shown that indomethacin is not a strong inhibitor when leukotriene A4 serves as a substrate for any of the enzyme forms tested (L. Orning, M. S6derstr6m, S. Hammarstr6m & B. Mannervik, unpublished work), and, secondly, the major part of the leukotriene C4 synthesis in vivo is carried out by a membrane-bound protein, leukotriene C synthase (Bach et al., 1984; Jakschik et al., 1982; Yoshimoto et al., 1985) . This enzyme is not significantly inhibited by indomethacin (Soderstr6m et al., 1988) . We therefore conclude that the effect of indomethacin on glutathione transferase in vivo probably would affect primarily its detoxication function. 
